Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France

Blood (2023) 142 (24): 2119–2123.

https://doi.org/10.1182/blood.2023021670

Published: 2023

Includes: Supplemental data

Journal Articles

High Prevalence of Vulvar and Hepatic Manifestations in a Series of 18 Histiocytosis with Brafdel Mutations

Matthias Papo, Julien Haroche, Malik Da Silva, Zofia Helias-Rodzewicz, Vsevolod Potapenko, Suzanna Bota, Leguy-Seguin Vanessa, Stéphane Dominique, Marion Campana, Visal Keo, Zahir Amoura, Jean-Francois Emile

Blood (2023) 142 (Supplement 1): 6392.

https://doi.org/10.1182/blood-2023-174667

Published: 2023

Journal Articles

NT-Probnp and High-Sensitivity Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease

Levi-Dan Azoulay, Chezi Ganzel, Marine Bravetti, Zahir Amoura, Jean Donadieu, Philippe Cluzel, Fleur Cohen-Aubart, Julien Haroche

Blood (2022) 140 (Supplement 1): 3997–3998.

https://doi.org/10.1182/blood-2022-157532

Published: 2022

Journal Articles

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Fleur Cohen Aubart, Damien Roos-Weil, Marine Armand, Alice Marceau-Renaut, Jean-François Emile, Nicolas Duployez, Frédéric Charlotte, Stéphanie Poulain, Raphael Lhote, Zofia Hélias-Rodzewicz, Véronique Della-Valle, Olivier Bernard, Karim Maloum, Florence Nguyen-Khac, Jean Donadieu, Zahir Amoura, Omar Abdel-Wahab, Julien Haroche

Blood (2021) 137 (4): 485–492.

https://doi.org/10.1182/blood.2020005101

Published: 2021

Includes: Supplemental data

Journal Articles

Pure Red Cell Aplasia in Systemic Lupus Erythematosus, a Nationwide Retrospective Cohort and Review of the Literature

Herv\xC3(c) Lobbes, Matthieu Mahevas, Sophie Alviset, MD, Lionel Galicier, MD, Nathalie Costedoat-Chalumeau, MD PhD, Zahir Amoura, MD PhD, Laurent Alric, MD PhD, Arnaud Hot, MD PhD, St\xC3(c)phane Durupt, MD, Marc Michel, Bertrand Godeau

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-133777

Published: 2020

Journal Articles

Erdheim-Chester disease

Julien Haroche, Fleur Cohen-Aubart, Zahir Amoura

Blood (2020) 135 (16): 1311–1318.

https://doi.org/10.1182/blood.2019002766

Published: 2020

Journal Articles

High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment

Anaïs Roeser, MD, Marine Bravetti, MD, Levi-Dan Azoulay, MD, Makoto Miyara, MD, Jean-François Emile, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Fleur Cohen-Aubart, MD PhD, Julien Haroche

Blood (2019) 134 (Supplement_1): 2324.

https://doi.org/10.1182/blood-2019-129984

Published: 2019

Journal Articles

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Fleur Cohen-Aubart, MD PhD, Ahmed Idbaih, MD PhD, Damien Galanaud, MD PhD, Bruno Law-Ye, MD, Jean-François Emile, MD PhD, Frédéric Charlotte, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Julien Haroche

Blood (2019) 134 (Supplement_1): 4272.

https://doi.org/10.1182/blood-2019-130606

Published: 2019

Journal Articles

PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease

Frédéric Charlotte, MD, Fleur Cohen-Aubart, MD PhD, Levi-Dan Azoulay, MD, Jean Donadieu, MD PhD, Jean-François Emile, MD PhD, Zahir Amoura, MD, Julien Haroche

Blood (2018) 132 (Supplement 1): 4380.

https://doi.org/10.1182/blood-2018-99-114031

Published: 2018

Journal Articles

Clonal Hematopoiesis in Erdheim-Chester Disease

Julien Haroche, MD PhD, Stéphanie Poulain, MD PhD, Alice Marceau-Renaut, PharmD, Aline Renneville, Catherine Settegrana, Karim Maloum, Damien Roos-Weil, Florence Nguyen-Khac, MD PhD, Jean Donadieu, MD, Jean-François Emile, MD PhD, Zahir Amoura, Fleur Cohen-Aubart, MD PhD

Blood (2017) 130 (Supplement 1): 3788.

https://doi.org/10.1182/blood.V130.Suppl_1.3788.3788

Published: 2017

Journal Articles

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

Fleur Cohen Aubart, Jean-François Emile, Fabrice Carrat, Frédéric Charlotte, Neila Benameur, Jean Donadieu, Philippe Maksud, Ahmed Idbaih, Stéphane Barete, Khê Hoang-Xuan, Zahir Amoura, Julien Haroche

Blood (2017) 130 (11): 1377–1380.

https://doi.org/10.1182/blood-2017-03-771873

Published: 2017

Includes: Supplemental data

Journal Articles

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Blood (2017) 130 (8): 1007–1013.

https://doi.org/10.1182/blood-2017-01-761718

Published: 2017

Includes: Supplemental data

Journal Articles

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Blood (2017) 130 (2): 176–180.

https://doi.org/10.1182/blood-2016-12-757377

Published: 2017

Includes: Supplemental data

Journal Articles

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Alexandra Serris, MD, Zahir Amoura, MD MSc, Benjamin Terrier, MD PhD, Eric Hachulla, MD PhD, Nathalie Costedoat-Chalumeau, MD PhD, Thomas Papo, MD, Olivier Lambotte, MD PhD, David Saadoun, MD PhD, Miguel Hie, MD, Philippe Blanche, Corinne Haioun, MD, Bertrand Lioger, Bertrand Godeau, MD PhD, Marc Michel, MD

Blood (2016) 128 (22): 870.

https://doi.org/10.1182/blood.V128.22.870.870

Published: 2016

Journal Articles

Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses

Benjamin Heath Durham, MD BS, Akihide Yoshimi, MD PhD, Matthias Papo, Young Rock Chung, MS, Neval Ozkaya, MD, Chezi Ganzel, Ahmet Dogan, David M. Hyman, Christopher Y. Park, MD PhD, Raajit K. Rampal, MD, PhD, Damien Roos Weil, Francois Michel Lemoine, MD PhD, Zahir Amoura, Olivier A. Bernard, PhD, Eli L. Diamond, MD, Jean-François Emile, MD PhD, Julien Haroche, MD PhD, Omar Abdel-Wahab, MD

Blood (2016) 128 (22): 951.

https://doi.org/10.1182/blood.V128.22.951.951

Published: 2016

Journal Articles

Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort

Louis Terriou, MD, Zelie Guitton, MD, Miguel Hie, MD, Zahir Amoura, MD MSc, James B. Bussel, MD, Mohamed Hamidou, MD PhD, Eric Rosenthal, MD, jean-Christophe Lega, MD, Raphaele nove-Josserand, MD, Bertrand Lioger, MD, Axel Chaminade, MD, Nadine magy-Bertrand, MD PhD, Sylvain Audia, MD PhD, Matthieu Mahevas, MD PhD, Bertrand Godeau, MD PhD

Blood (2016) 128 (22): 2542.

https://doi.org/10.1182/blood.V128.22.2542.2542

Published: 2016

Journal Articles

Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease

Fleur Cohen-Aubart, Philippe Maksud, David Saadoun, Aurélie Drier, Frédéric Charlotte, Philippe Cluzel, Zahir Amoura, Julien Haroche

Blood (2016) 127 (11): 1509–1512.

https://doi.org/10.1182/blood-2015-09-672667

Published: 2016

Journal Articles

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

Benjamin Heath Durham, MD BS, Eli L. Diamond, MD, Julien Haroche, MD PhD, Zhan Yao, PhD, Jing Ma, PhD, Sameer A. Parikh, MD, John Choi, Eunhee Kim, PhD, Fleur Cohen-Aubart, Stanley Chun-Wei Lee, Yijun Gao, Jean-Baptiste Micol, MD, Patrick Campbell, MD PhD, Michael P. Walsh, Brooke Sylvester, Igor Dolgalev, Aminova Olga, Adriana Heguy, Paul Zappile, Joy Nakitandwe, BSc,MSc,PhD, James Dalton, BS, David W Ellison, MD, Juvianee Estrada-Veras, Mario Lacouture, William A. Gahl, MD PhD, Phil Stephens, PhD, Vincent A. Miller, MD, Jeffrey Ross, Siraj Ali, Sebastien Héritier, Jean Donadieu, MD PhD, David Solit, MD, David M. Hyman, Jose Baselga, MD PhD, Filip Janku, MDPhD, Barry S. Taylor, PhD, Christopher Y. Park, MD, PhD, Ahmet Dogan, MD PhD, Zahir Amoura, Jean-Francois Emile, Raajit K. Rampal, MD, PhD, Neal Rosen, MD PhD, Tanja A. Gruber, MD PhD, Omar Abdel-Wahab

Blood (2015) 126 (23): 481.

https://doi.org/10.1182/blood.V126.23.481.481

Published: 2015

Journal Articles

mTOR: a new target in Erdheim-Chester disease?

Julien Haroche, Zahir Amoura

Blood (2015) 126 (10): 1151–1152.

https://doi.org/10.1182/blood-2015-07-650796

Published: 2015

Journal Articles

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Blood (2014) 124 (21): 3254.

https://doi.org/10.1182/blood.V124.21.3254.3254

Published: 2014

NARROW

Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France

High Prevalence of Vulvar and Hepatic Manifestations in a Series of 18 Histiocytosis with Brafdel Mutations

NT-Probnp and High-Sensitivity Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Pure Red Cell Aplasia in Systemic Lupus Erythematosus, a Nationwide Retrospective Cohort and Review of the Literature

Erdheim-Chester disease

High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease

Clonal Hematopoiesis in Erdheim-Chester Disease

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Can Rituximab be Useful for Treating SLE-Associated Immune Cytopenias ? Results from a Retrospective Multicentre Study on 62 Patients

Frequent Clinical Overlap of Histiocytic Neoplasms and WHO-Classified Myeloid Malignancies Leads to Functional Insights into the Cell-of-Origin of Histiocytoses

Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort

Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

mTOR: a new target in Erdheim-Chester disease?

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only